| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 154, Issue 9 4322-4332, Copyright © 1995 by American Association of Immunologists
ARTICLES |
G Hajishengallis, SK Hollingshead, T Koga and MW Russell
Department of Microbiology, University of Alabama at Birmingham 35294, USA.
The generation of secretory IgA Abs for specific immune protection of mucosal surfaces depends on stimulation of the mucosal immune system, but this is not effectively achieved by parenteral or even oral administration of most soluble Ags. To harness the exceptional mucosal immunogenicity of cholera toxin (CT), which is largely attributed to the cell-binding property of its B subunit, for the generation of other oral vaccines, we have genetically replaced the toxic A1 subunit of CT with a 42-kDa segment of a streptococcal protein adhesin. This construct was expressed in Escherichia coli as a chimeric protein that retained the GM1 ganglioside-binding activity of CT subunit B and the antigenicity of the streptococcal adhesin, as shown by GM1-ELISA developed with Abs to the steptococcal segment. The protein composition of chromatographically purified chimeric protein was verified by SDS- PAGE and Western blotting with Abs to both antigenic components of the construct. Peroral administration of this chimeric immunogen in mice elicited high levels of mucosal IgA and serum IgG Abs to the streptococcal adhesin, which persisted for at least 6 mo. This strategy allows the development of similar constructs from other candidate Ags for oral immunization against a variety of mucosally acquired infections.
This article has been cited by other articles:
|
|
 |
|
  J. Mestecky, M. W. Russell, and C. O. Elson Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier? J. Immunol., November 1, 2007; 179(9): 5633 - 5638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Hajishengallis, S. Arce, C.M. Gockel, T.D. Connell, and M.W. Russell Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections J. Dent. Res., December 1, 2005; 84(12): 1104 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Harakuni, H. Sugawa, A. Komesu, M. Tadano, and T. Arakawa Heteropentameric Cholera Toxin B Subunit Chimeric Molecules Genetically Fused to a Vaccine Antigen Induce Systemic and Mucosal Immune Responses: a Potential New Strategy To Target Recombinant Vaccine Antigens to Mucosal Immune Systems Infect. Immun., September 1, 2005; 73(9): 5654 - 5665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Price, M. W. Russell, and C. N. Cornelissen Intranasal Administration of Recombinant Neisseria gonorrhoeae Transferrin Binding Proteins A and B Conjugated to the Cholera Toxin B Subunit Induces Systemic and Vaginal Antibodies in Mice Infect. Immun., July 1, 2005; 73(7): 3945 - 3953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. Nawar, S. Arce, M. W. Russell, and T. D. Connell Mucosal Adjuvant Properties of Mutant LT-IIa and LT-IIb Enterotoxins That Exhibit Altered Ganglioside-Binding Activities Infect. Immun., March 1, 2005; 73(3): 1330 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Li, J. L. Erbe, C. V. Lockatell, D. E. Johnson, M. G. Jobling, R. K. Holmes, and H. L. T. Mobley Use of Translational Fusion of the MrpH Fimbrial Adhesin-Binding Domain with the Cholera Toxin A2 Domain, Coexpressed with the Cholera Toxin B Subunit, as an Intranasal Vaccine To Prevent Experimental Urinary Tract Infection by Proteus mirabilis Infect. Immun., December 1, 2004; 72(12): 7306 - 7310. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hajishengallis, H. Nawar, R. I. Tapping, M. W. Russell, and T. D. Connell The Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb and Their Respective B Pentamers Differentially Induce and Regulate Cytokine Production in Human Monocytic Cells Infect. Immun., November 1, 2004; 72(11): 6351 - 6358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. A. Price, M. M. Hobbs, and C. N. Cornelissen Immunogenicity of Gonococcal Transferrin Binding Proteins during Natural Infections Infect. Immun., January 1, 2004; 72(1): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Lee, S. A. Halperin, D. F. Salloum, A. MacMillan, and A. Morris Mucosal Immunization with a Genetically Engineered Pertussis Toxin S1 Fragment-Cholera Toxin Subunit B Chimeric Protein Infect. Immun., April 1, 2003; 71(4): 2272 - 2275. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. LOPEZ-MONTEON, A. RAMOS-LIGONIO, L. PEREZ-CASTILLO, P. TALAMAS-ROHANA, and J. L. ROSALES-ENCINA Specific antibody immune response against the parasitic portion of a glutathione-S-transferase fusion protein FASEB J, April 1, 2003; 17(6): 621 - 627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhang, C. Jespersgaard, L. Lamberty-Mallory, J. Katz, Y. Huang, G. Hajishengallis, and S. M. Michalek Enhanced Immunogenicity of a Genetic Chimeric Protein Consisting of Two Virulence Antigens of Streptococcus mutans and Protection against Infection Infect. Immun., December 1, 2002; 70(12): 6779 - 6787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Lee, S. A. Halperin, J. B. Knight, and A. Tait Purification and Immunogenicity of a Recombinant Bordetella pertussis S1S3FHA Fusion Protein Expressed by Streptococcus gordonii Appl. Envir. Microbiol., September 1, 2002; 68(9): 4253 - 4258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.J. Smith DENTAL CARIES VACCINES: PROSPECTS AND CONCERNS Crit. Rev. Oral. Biol. Med., July 1, 2002; 13(4): 335 - 349. [Abstract] [Full Text]
|
|
|
|
|
|
C. Jespersgaard, P. Zhang, G. Hajishengallis, M. W. Russell, and S. M. Michalek Effect of Attenuated Salmonella enterica Serovar Typhimurium Expressing a Streptococcus mutans Antigen on Secondary Responses to the Cloned Protein Infect. Immun., November 1, 2001; 69(11): 6604 - 6611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, G. Hajishengallis, and S. M. Michalek Induction of Protective Immunity against Streptococcus mutans Colonization after Mucosal Immunization with Attenuated Salmonella enterica Serovar Typhimurium Expressing an S. mutans Adhesin under the Control of In Vivo-Inducible nirB Promoter Infect. Immun., April 1, 2001; 69(4): 2154 - 2161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Martin, G. Hajishengallis, D. J. Metzger, S. M. Michalek, T. D. Connell, and M. W. Russell Recombinant Antigen-Enterotoxin A2/B Chimeric Mucosal Immunogens Differentially Enhance Antibody Responses and B7-Dependent Costimulation of CD4+ T Cells Infect. Immun., January 1, 2001; 69(1): 252 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-Y. Wu, S. Abdu, D. Stinson, and M. W. Russell Generation of Female Genital Tract Antibody Responses by Local or Central (Common) Mucosal Immunization Infect. Immun., October 1, 2000; 68(10): 5539 - 5545. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Bolduc, V. Bouchet, R.-Z. Jiang, J. Geisselsoder, Q. C. Truong-Bolduc, P. A. Rice, S. I. Pelton, and R. Goldstein Variability of Outer Membrane Protein P1 and Its Evaluation as a Vaccine Candidate against Experimental Otitis Media due to Nontypeable Haemophilus influenzae: an Unambiguous, Multifaceted Approach Infect. Immun., August 1, 2000; 68(8): 4505 - 4517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. Minion, C. Adams, and T. Hsu R1 Region of P97 Mediates Adherence of Mycoplasma hyopneumoniae to Swine Cilia Infect. Immun., May 1, 2000; 68(5): 3056 - 3060. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, G. Hajishengallis, and S. M. Michalek Construction and Characterization of a Salmonella enterica Serovar Typhimurium Clone Expressing a Salivary Adhesin of Streptococcus mutans under Control of the Anaerobically Inducible nirB Promoter Infect. Immun., March 1, 2000; 68(3): 1549 - 1556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jespersgaard, G. Hajishengallis, Y. Huang, M. W. Russell, D. J. Smith, and S. M. Michalek Protective Immunity against Streptococcus mutans Infection in Mice after Intranasal Immunization with the Glucan-Binding Region of S. mutans Glucosyltransferase Infect. Immun., December 1, 1999; 67(12): 6543 - 6549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Hedges, M. S. Mayo, J. Mestecky, E. W. Hook III, and M. W. Russell Limited Local and Systemic Antibody Responses to Neisseria gonorrhoeae during Uncomplicated Genital Infections Infect. Immun., August 1, 1999; 67(8): 3937 - 3946. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Michalek, N. K. Childers, T. Greenway, G. Hajishengallis, and J. T. Ulrich Monophosphoryl lipid A: an effective adjuvant for potentiating mucosal immune responses Innate Immunity, June 1, 1999; 5(3): 181 - 182. [PDF]
|
|
|
|
|
|
L. C. Agren, L. Ekman, B. Lowenadler, J. G. Nedrud, and N. Y. Lycke Adjuvanticity of the Cholera Toxin A1-Based Gene Fusion Protein, CTA1-DD, Is Critically Dependent on the ADP-Ribosyltransferase and Ig-Binding Activity J. Immunol., February 15, 1999; 162(4): 2432 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Connell, D. J. Metzger, J. Lynch, and J. P. Folster Endochitinase Is Transported to the Extracellular Milieu by the eps-Encoded General Secretory Pathway of Vibrio cholerae J. Bacteriol., November 1, 1998; 180(21): 5591 - 5600. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Mora and J. P. Tam Controlled Lipidation and Encapsulation of Peptides as a Useful Approach to Mucosal Immunizations J. Immunol., October 1, 1998; 161(7): 3616 - 3623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Harokopakis, G. Hajishengallis, and S. M. Michalek Effectiveness of Liposomes Possessing Surface-Linked Recombinant B Subunit of Cholera Toxin as an Oral Antigen Delivery System Infect. Immun., September 1, 1998; 66(9): 4299 - 4304. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hajishengallis, M. W. Russell, and S. M. Michalek Comparison of an Adherence Domain and a Structural Region of Streptococcus mutans Antigen I/II in Protective Immunity against Dental Caries in Rats after Intranasal Immunization Infect. Immun., April 1, 1998; 66(4): 1740 - 1743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Marcotte and M. C. Lavoie Oral Microbial Ecology and the Role of Salivary Immunoglobulin A Microbiol. Mol. Biol. Rev., March 1, 1998; 62(1): 71 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Sultan, L.-l. Jin, M. G. Jobling, R. K. Holmes, and S. L. Stanley Jr. Mucosal Immunogenicity of a Holotoxin-Like Molecule Containing the Serine-Rich Entamoeba histolytica Protein (SREHP) Fused to the A2 Domain of Cholera Toxin Infect. Immun., February 1, 1998; 66(2): 462 - 468. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
